100
Views
5
CrossRef citations to date
0
Altmetric
Original Research

The Glasgow prognostic score can be a predictor of mortality in acute exacerbation of chronic obstructive pulmonary disease

& ORCID Icon
Pages 521-525 | Received 20 Sep 2019, Accepted 24 Feb 2020, Published online: 09 Mar 2020

References

  • Rebublic of Turkey ministry of health Refik Saydam hygiene center presidency school of public health. Turkey national burden of disease and cost effectiveness study: national household survey 2003. Basic Findings. Ankara, Turkey 2006.
  • Republic of Turkey ministry of health Refik Saydam hygiene center presidency school of public health. Turkey Burden of Disease Study 2004. Ankara, Turkey, 2006.
  • Connors AF Jr, Dawson NV, Thomas C, et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease: study to understand prognoses and preferences for outcomes and risks of treatments. Am J Respir Crit Care Med. 1996;154(4 Pt 1):959–967.
  • Groenewegen KH, Schols AM, Wouters EF. Mortality and mortality related factors after hospitalization for acute exacerbation of COPD. Chest. 2003;124(2):459–467.
  • National Institute for Health and Clinical Excellence (NICE). NICE clinical guideline 101: chronic obstructive pulmonary disease. [cited 2012 Jan 8]. Available from: http://www.nice.org.uk/nicemedia/live/13029/49397/49397.pdf
  • American Thoracic Society, European Respiratory Society. Standards for the diagnosis and management of patients with COPD [ cited 2012 Jan 8]. Available from: http://www.thoracic.org/clinical/copd-guidelines/resources/copddoc.pdf
  • McMillan DC. An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer. Proc Nutr Soc. 2008;67(3):257–262.
  • Kobayashi T, Teruya M, Kishiki T, et al. Inflammation-based prognostic score, prior to neoadjuvant chemoradiotherapy, predicts postoperative outcome in patients with esophageal squamous cell carcinoma. Surgery. 2008;144(5):729–735.
  • Forrest LM, McMillan DC, McArdle CS, et al. Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG) in patients receiving platinum-based chemotherapy for inoperable non-small-cell lung cancer. Br J Cancer. 2004;90(9):1704–1706.
  • Wedzicha JA, Donaldson GC. Exacerbations of chronic obstructive pulmonary disease. Respir Care. 2003;48(12):1204–1213.
  • Karadeniz G, Polat G, Senol G, et al. C-reactive protein measurements as a marker of the severity of chronic obstructive pulmonary disease exacerbations. Inflammation. 2013;36(4):948–953.
  • From the global strategy for the diagnosis, management and prevention of COPD, global initiative for chronic obstructive lung disease (GOLD) 2010. Manage exacerbations: Chapter 5 (Component 4); 64–90.
  • Anthonisen NR, Manfreda J, Warren CP, et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 1987;106(2):196–204.
  • Mc Millan DC. Systemic inflammation, nutritional status and survival in patients with cancer. Curr Opin Clin Nutr Metab Care. 2009;12(3):223–226.
  • Quanjer H, Tammeling GJ, Cotes JE, et al. Lung volumes and forced ventilatory flows. Eur Respir J. 1993;6(Suppl 16):5-40.
  • Spencer S, Jones PW. Time course of recovery of health status following an infective exacerbation of chronic bronchitis. Thorax. 2003;58(7):589–593.
  • Donaldson GC, Seemungal TA, Bhowmik A, et al. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax. 2002;57(10):847–852.
  • Patil SP, Krishnan JA, Lechtzin N, et al. In-hospital mortality following acute exacerbations of chronic obstructive pulmonary disease. Arch Intern Med. 2003;163(10):1180–1186.
  • Price LC, Lowe D, Hosker HS, et al. UK National COPD Audit 2003: impact of hospital resources and organisation of care on patient outcome following admission for acute COPD exacerbation. Thorax. 2006;61(10):837–842.
  • Halpin DMG, Decramer M, Celli B, et al. Exacerbation frequency and course of COPD. Int J COPD. 2012;7:653–661.
  • Fuso L, Incalzi RA, Pistelli R, et al. Predicting mortality of patients hospitalized for acutely exacerbated chronic obstructive pulmonary disease. Am J Med. 1995;98(3):272–277.
  • Warren PM, Flenley DC, Millar JS, et al. Respiratory failure revisited: acute exacerbations of chronic bronchitis between 1961–68 and 1970–76. Lancet. 1980;1(8166):467–470.
  • Jeffrey AA, Warren PM, Flenley DC. Acute hypercapnic respiratory failure in patients with chronic obstructive lung disease: risk factors and use of guidelines for management. Thorax. 1992;47(1):34–40.
  • Portier F, Defouilloy C, Muir JF. Determinants of immediate survival among chronic respiratory insufficiency patients admitted to an intensive care unit for acute respiratory failure. A prospective multicenter study. The French task group for acute respiratory failure in chronic respiratory insufficiency. Chest. 1992;101(1):204–210.
  • Heuser MD, Case LD, Ettinger WH. Mortality in intensive care patients with respiratory disease. Is age important? Arch Intern Med. 1992;152(8):1683–1688.
  • Steer J, Norman EM, Afolabi OA, et al. Dyspnoea severity and pneumonia as predictors of in-hospital mortality and early readmission in acute exacerbations of COPD. Thorax. 2012;67(2):117–121.
  • Faner R, Tal-Singer R, Riley JH, et al. Lesson from ECLIPSE: a review of COPD biomarkers. Thorax. 2014;69(7):666–672.
  • Perera WR, Hurst JR, Wilkinson TM, et al. Inflamatory changes, recovery and recurrence at COPD exacerbation. Eur Respir J. 2007;29(3):527–534.
  • Dahl M, Vestbo J, Lange P, et al. C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007;175(3):250–255.
  • Mantero M, Rogliani P, Di Pasquale M, et al. Acute exacerbations of COPD: risk factors for failure and relapse. Int J Chron Obstruct Pulmon Dis. 2017;12:2687–2693.
  • Crisafulli E, Torres A, Huerta A, et al. Predicting in-hospital treatment failure (≤7 days) in patients with COPD exacerbation using antibiotics and systemic steroids. COPD. 2016;13(1):82–92.
  • Ruiz-González A, Lacasta D, Ibarz M, et al. C-reactive protein and other predictors of poor outcome in patients hospitalized with exacerbations of chronic obstructive pulmonary disease. Respirology. 2008;13(7):1028–1033.
  • Asiimwe AC, Brims FJ, Andrews NP, et al. Routine laboratory tests can predict in-hospital mortality in acute exacerbations of COPD. Lung. 2011;189(3):225–232.
  • Landbo C, Prescott E, Lange P, et al. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;160(6):1856–1861.
  • McMillan DC. The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer. Cancer Treat Rev. 2013;39(5):534–540.
  • Dupre A, Malik HS. Inflammation and cancer: what a surgical oncologist should know. Eur J Surg Oncol. 2018;44(5):566–570.
  • Margarson MP, Soni N. Serum albumin: touchstone or totem? Anaesthesia. 1998;53(8):789–803.
  • Wouters EF. Local and systemic inflammation in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2005;2(1):26–33.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.